why choose us

First received: December 09, 2022

Clinical Trial: ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Study Status: Completed

Recruit Status: RECRUITING

Condition: Immunodeficiency

Study Type: INTERVENTIONAL


Official Title: ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Brief Summary: The investigators will examine whether a combination of at-home nucleic acid amplification tests, on-demand telemedicine, and delivery of prescriptions such as Paxlovid quickly after testing positive for COVID-19, can reduce severe outcomes and hospitalization of immunocompromised patients and those who are 65 years and older.They will also analyze whether these efforts lower the cost of care compared to standard of care.

Read more